Form 8-K
8-K — Covista Inc.
Accession: 0000730464-26-000015
Filed: 2026-04-09
Period: 2026-04-09
CIK: 0000730464
SIC: 8200 (SERVICES-EDUCATIONAL SERVICES)
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — cvsa-20260409x8k.htm (Primary)
EX-99.1 (cvsa-20260409xex99d1.htm)
GRAPHIC (cvsa-20260409x8k001.jpg)
GRAPHIC (cvsa-20260409xex99d1g001.jpg)
GRAPHIC (cvsa-20260409xex99d1g002.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: cvsa-20260409x8k.htm · Sequence: 1
Covista Inc._April 9, 2026
0000730464false00007304642026-04-092026-04-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 9, 2026
Covista Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-13988
36-3150143
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
233 South Wacker Drive
Chicago, IL
60606
(Address of principal executive offices)
(Zip Code)
(312) (651-1400)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on
which registered
Common Stock $0.01 Par Value
CVSA
New York Stock Exchange
Common Stock $0.01 Par Value
CVSA
NYSE Texas
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01Regulation FD Disclosure
On April 9, 2026, Covista Inc. (“Covista”) released an investor newsletter, which provided updates on key milestones, strategic developments, and operational progress. The investor newsletter is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Covista under the Securities Act of 1933, as amended, or the Exchange Act.
Cautionary Disclosure Regarding Forward-Looking Statements
Certain statements contained in this Form 8-K and related newsletter are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Covista’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Covista assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.
Item 9.01 Financial Statements and Exhibits
99.1
Investor Newsletter dated April 9, 2026
104
Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Covista Inc.
By:
/s/ Robert J. Phelan
Robert J. Phelan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
Date: April 9, 2026
EX-99.1
EX-99.1
Filename: cvsa-20260409xex99d1.htm · Sequence: 2
Exhibit 99.1
The U.S. healthcare workforce shortage requires more than
just growing the supply through strong education, it also
must solve the access problem, particularly in some of the
most underserved areas like rural communities. This requires
collaboration across the entire healthcare ecosystem. In
February, Covista announced it was a founding member of
the Alliance for Advancing Rural Healthcare (AARH), bringing
together a consortium of leading healthcare organizations to
help state governments execute the federal Rural Health
Transformation, a federal initiative designed to strengthen
healthcare systems across rural and local communities.
Covista contributes to the AARH its scale as America's largest
healthcare educator, and its focus on partnering with health
systems to place graduates in underserved communities and
improve access to care closer to home. The need in rural
America is critical, as 85% of healthcare executives in those
communities say they can’t find enough local talent.
Through partnerships such as this, Covista is increasingly a
part of the structural solutions to America's healthcare crisis,
creating durable demand for its graduates and deepening
relationships on a national stage with health systems and
government agencies.
3
Covista at the forefront of rural
healthcare: partnering to build the
workforce America needs
A note from our CEO
Welcome to the inaugural edition
of Covista's investor newsletter —
a forum we created with a clear
purpose: to bring you closer to our
team, our thinking, and our story.
In this and every edition that follows, you will find
important updates on key milestones, strategic
developments, and operational progress — the things
we believe matter most to the long-term value of this
business, beyond what we cover on our quarterly
earnings calls.
To understand where Covista is headed, there is no better
starting point than our February Investor Day, a milestone
moment for the company and, we believe, a defining
one for how the market comes to understand the scale
of our opportunity.
At the center of the event was the formal introduction of
Purpose at Scale, our next three-year strategy and the
natural evolution of Growth with Purpose, our approach
that transformed Covista into essential infrastructure for
America's healthcare workforce pipeline. Purpose at Scale
is paired with attractive long-term financial targets through
FY2029: revenue growth at a CAGR of 7–10%, Adjusted
EPS growth at a CAGR of 10–14%, and enrollment
exceeding 120,000 students.¹˒²
Where our prior strategy set the table, Purpose at Scale
lays out the roadmap for Covista to become the defining,
scaled solution to the nation's healthcare workforce
crisis — not simply as an education provider, but as a true
talent platform, working hand-in-hand with health systems
and employer partners across the country.
The strategy is organized around four core principles:
operational excellence, platform extension, employer
integration, and a focused commitment to technology.
As we deepen direct partnerships with health systems
and lead the industry on AI-enabled learning, we are
positioning Covista to make education more effective,
more accessible, and more valuable for both students
and the employers who depend on them.
Investor Day also coincided with two proud milestones, the
ringing of the NYSE closing bell to commemorate our ticker
change to CVSA, and the debut of our brand on a Times
Square digital billboard. It was a fitting backdrop for our
next chapter.
The strategy is clear, the team is aligned, and the
opportunity in front of us is real. America's healthcare
workforce crisis is not waiting, and neither are we. We look
forward to keeping you informed every step of the way.
Steve Beard
Chairman and CEO, Covista
PARTNERSHIP UPDATE
In the News
1.Wall Street Journal: One
CEO’s Bet on a Burgeoning
Healthcare Labor Market
2.Crain’s Business: Nursing
schools are racing to stave
off a looming workforce crisis
3.Crain’s Business: Rebranded
Covista detail ambitious
growth plans
4.Punchbowl: Covista
executives Michael Betz and
Megan Noel present at
Punchbowl News Conference
Covista sets the standard: strategic depth and national impact
Spring 2026
WATCH OUR NYSE INTERVIEW Covista recently announced a significant
leadership appointment at the Ross
University School of Medicine (RUSM),
underscoring management's commitment
to pairing the company's growing scale
with best-in-class academic leadership.
Mark your calendars for
Covista’s third quarter
earnings call, taking
place on May 7, 2026.
Covista welcomes new leader to
drive student success
Dr. Cheryl Holmes joined in March as the new Dean of
RUSM, bringing more than 30 years of clinical experience in
family medicine and critical care, along with a strong record in
education, research, and academic leadership. Her appointment
comes as RUSM has cemented its leadership position,
graduating more M.D.s than any other U.S. medical school and
having graduated more than 16,000 alumni.
Reflecting a deliberate strategy to deepen operational
excellence, strengthen student outcomes and reinforce the
company's competitive moat as America's largest healthcare
educator, Covista is investing in the right leaders at the right
time to sustain momentum and continue expanding access to
healthcare careers across its five accredited institutions.
Employer integration is a key pillar of Covista’s Purpose at
Scale strategy. By creating deep partnerships with healthcare
systems, similar to our existing partnership with SSM Health,
we can collectively create proprietary workforce pipelines that
drive enrollment and connect graduates directly to employment.
Covista released its Care Capacity Monitor that shows that
healthcare employers want more than just graduates, they want
in the trenches partners who can: lower the cost of acquiring
talent, raise productivity, and improve the retention of their
employees. Our long track record of outcomes and national
scale enables us to become the preferred workforce solutions
partner and in doing so, we can create a durable model with
compounding value for students, health systems and Covista.
And the strategic rationale is well-supported by Covista’s
own research; nearly 70% of healthcare executives list talent
partnerships as very or somewhat effective for meeting their
workforce needs, even more so than hiring and retention
bonuses, upskilling existing staff or using staffing agencies
3
and online hiring forums.
Covista data shows its talent
partnership strategy is directly
aligned with healthcare executives
staffing needs
COVISTA RESEARCH LEADERSHIP UPDATE WHAT’S NEXT 1: Revenue & adj. EPS CAGR based on midpoint of FY26 guidance (Revenue range $1,900m-$1,940m; midpoint is $1,920m | adj. EPS range $7.80-$8.00; midpoint is $7.90) 2: A reconciliation of non-GAAP guidance
measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of special items that may be incurred in the future, although these special items
could be material to Covista's results in accordance with GAAP. 3: Covista Care Capacity Monitor: Research | Covista Care Capacity Monitor | Covista
Note: This Investor Newsletter contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and involve risks and
uncertainties that could cause actual results to differ materially from those expressed or implied.
To subscribe to future newsletters, please contact investor.relations@covista.com
Spring 2026
Covista sets the standard: strategic depth and national impact
Chamberlain University
debuts new brand campaign
Chamberlain’s new marketing
campaign brings to life the heart of
nursing through authentic, emotionally
resonant storytelling. The campaign is
anchored by two new videos that
spotlight the compassion, camaraderie,
and calling that define the nursing
profession, creating meaningful
connections with both prospective
and current students.
MARKETING UPDATE Raising brand awareness is an important driver of new
enrollment and a key pillar of Chamberlain's go-to-market
strategy; we expect this campaign to be a contributor for our
enrollment initiatives as we look to close out fiscal year 2026
and build momentum heading into fiscal year 2027.
GRAPHIC
GRAPHIC
Filename: cvsa-20260409x8k001.jpg · Sequence: 3
Binary file (875 bytes)
Download cvsa-20260409x8k001.jpg
GRAPHIC
GRAPHIC
Filename: cvsa-20260409xex99d1g001.jpg · Sequence: 4
Binary file (301388 bytes)
Download cvsa-20260409xex99d1g001.jpg
GRAPHIC
GRAPHIC
Filename: cvsa-20260409xex99d1g002.jpg · Sequence: 5
Binary file (287952 bytes)
Download cvsa-20260409xex99d1g002.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 11
v3.26.1
Document and Entity Information
Apr. 09, 2026
Document and Entity Information [Abstract]
Document Type
8-K
Document Period End Date
Apr. 09, 2026
Entity File Number
001-13988
Entity Registrant Name
Covista Inc.
Entity Incorporation, State or Country Code
DE
Entity Tax Identification Number
36-3150143
Entity Address, Address Line One
233 South Wacker Drive
Entity Address, City or Town
Chicago
Entity Address, State or Province
IL
Entity Address, Postal Zip Code
60606
City Area Code
312
Local Phone Number
651-1400
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock $0.01 Par Value
Trading Symbol
CVSA
Security Exchange Name
NYSE
Entity Emerging Growth Company
false
Entity Central Index Key
0000730464
Amendment Flag
false
X
- References
No definition available.
+ Details
Name:
cvsa_DocumentAndEntityInformationAbstract
Namespace Prefix:
cvsa_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration